🇺🇸 FDA
Patent

US 8106131

Hydrolytically stable maleimide-terminated polymers

granted A61KA61K47/60

Quick answer

US patent 8106131 (Hydrolytically stable maleimide-terminated polymers) held by Nektar Therapeutics expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K47/60